Ranbaxy starts phase III study of anti-malaria drug
Ranbaxy starts phase III study of anti-malaria drug

Ranbaxy Laboratories announced that its new anti-malarial combination drug is now undergoing final stage of development. In its press-release, the company said that the drug is targeted at patients in developing countries with the aim of significantly improving upon the conventional options available for the treatment of P falciparum malaria.

NEWS REVIEW – WORLD
NEWS REVIEW – WORLD

[This article was published in the February 2009 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]

Greek scientists have developed heart attack calculator.

Eye in the sky
Eye in the sky

[This article was published in the December 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]

Technology can be seductive, particularly in healthcare. Unfortunately, all too often the focus of programs and �research� becomes the technology itself rather than the outcome. Informatics based early warning systems for epidemics are a step in the right direction.

Point of care monitoring expands market
Point of care monitoring expands market

Patients wary of medical negligence and unnecessary tests by doctors need not be nervous at the time of hospitalisation anymore. The government is in the process of framing clinical guidelines for the treatment of widely-prent diseases. Doctors would have to follow these guidelines.

India and France to cooperate in the health sector
India and France to cooperate in the health sector

Union Health Minister, Dr. Anbumani Ramadoss, currently on an official visit to France, discussed cooperation in certain fields such as Medical Research, Biotechnology, Development of vaccine, Promotion of Indian Systems of medicines and cooperation between ICMR and INSERM of France

whatsapp--v1